Hmgi-c is a member of a novel, developmentally regulated gene family. It is responsible for the pygmy (pg) mutation in mouse and the human homologue is disrupted in a number of tumors. Therefore, this proposal is an attempt to understand the function of Hmgi-c and its role in the interdependent processes of proliferation and tumorigenesis. Based on the human tumor studies, the first specific aim will investigate the nature of the HMGI-C gene products required in tumorigenesis. Transgenic mice will be generated that harbor various HMGI-C transgenes whose structure is similar to that seen in human tumors. Transgenic mice which express wildtype HMGI-C in an inappropriate cell type will be analyzed for tumor formation and the tumors characterized for activation of the endogenous Hmgi-c alleles. Tissue culture studies imply that HMGI-C is necessary for tumorigenesis. Therefore, the second aim will examine the susceptibility of the pg mouse mutant to tumorigenesis by different oncogenic stimuli in various tissues.
The third aim will analyze the effect of Hmgi-c expression on proliferation and the cell cycle. This will be performed on pg and wildtype embryonic fibroblasts grown under different culture conditions. Finally, in order to elucidate the molecular components of the Hmgi-c pathway, putative target genes will be identified by differential display. The long term objectives are to understand the role of Hmgi-c in growth and development. This will ultimately explain the phenotype of the pygmy mouse and how its disruption or deregulation leads to tumorigenesis including uterine leiomyoma, a major cause of hysterectomy in humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA077929-05
Application #
6513227
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Pelroy, Richard
Project Start
1998-06-01
Project End
2004-03-31
Budget Start
2002-04-01
Budget End
2004-03-31
Support Year
5
Fiscal Year
2002
Total Cost
$287,580
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Biochemistry
Type
Schools of Medicine
DUNS #
622146454
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
D'Armiento, Jeanine; Imai, Kazushi; Schiltz, John et al. (2007) Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis. Cancer Res 67:1902-9
Zaidi, M Raza; Okada, Yasunori; Chada, Kiran K (2006) Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. Cancer Res 66:7453-9
Liu, Jun; Schiltz, John F; Ashar, Hena R et al. (2003) Hmga1 is required for normal sperm development. Mol Reprod Dev 66:81-9
Benson, Kathleen F; Chada, Kiran (2002) Molecular characterization of the mouse In(10)17Rk inversion and identification of a novel muscle-specific gene at the proximal breakpoint. Genetics 160:279-87
Liu, J; Schiltz, J F; Shah, P C et al. (2000) Genomic structure and expression of the murine Hmgi(y) gene. Gene 246:197-207
Anand, A; Chada, K (2000) In vivo modulation of Hmgic reduces obesity. Nat Genet 24:377-80